Stockreport

Lexaria submits IND to begin Phase 1b study of DehyraTECH-CBD [Seeking Alpha]

Lexaria Bioscience Corp.  (LEXX) 
PDF The Canadian biotech company said it plans to begin the study once the IND is authorized, subject to certain conditions such as funding. DehydraTECH-CBD is cannabidio [Read more]